Rivaroxaban Oral Suspension (Anhydrous)
Rivaroxaban is a compounded formulation containing Rivaroxaban, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Rivaroxaban is a selective factor Xa inhibitor utilized in veterinary medicine for its anticoagulant properties. It is a prescription medication available for use in dogs and cats, requiring professional guidance and monitoring by a licensed veterinarian. It is frequently considered in the context of circulatory health for patients presented with a high risk of blood clots or thromboembolism.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it manages the coagulation cascade by inhibiting the activity of factor Xa, providing an approach for managing the formation of fibrin. Commonly observed effects include behavioral shifts such as lethargy and an increased risk of localized bleeding. Because it influences blood clotting, your veterinarian will monitor for observational signs of sensitivity through regular exams. Owners should monitor for any unusual bruising, pale gums or dark stools and contact their veterinarian promptly with any concerns regarding the patient's response.
Yes. Rivaroxaban is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab ensures all professional standards are met before dispensing.
Yes. Mixlab specializes in compounding rivaroxaban into customized strengths and flavored oral formats, such as flavored oral liquids or treats, to suit the specific needs of your pet.
Veterinarians discuss rivaroxaban for pets with heart or kidney challenges that may increase the risk of blood clots. This offers an approach to managing long-term circulatory safety during recovery.
Your veterinarian will recommend periodic check-ups to monitor for observational signs of bleeding. While it does not require frequent blood monitoring like some other anticoagulants, regular exams are important.
Because rivaroxaban manages blood clotting, even small wounds may take longer to stop bleeding. If you notice persistent bleeding, contact your veterinarian immediately for a clinical review.
